×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Stoke Therapeutics Inc (STOK) Reports Q1 2024 Financial Results: A Closer Look at Challenges ...
Yahoo Finance
Despite Narrow Miss on EPS, Stoke Therapeutics Advances in Clinical Developments.
5 days ago
Wilson Sonsini Advises Stoke Therapeutics on IP Matters Related to Upsized Public Offering
Wilson Sonsini
On March 28, 2024, Stoke Therapeutics, a biotechnology company focused on developing RNA-based medicines to treat severe diseases,...
1 month ago
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
Business Wire
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by...
2 weeks ago
Stoke Therapeutics Chief Financial Officer Stephen Tulipano Resigns
MarketWatch
By Colin Kellaher Stoke Therapeutics on Monday said its chief financial officer, Stephen Tulipano, has resigned, effective May 7.
2 weeks ago
Stoke Therapeutics (NASDAQ:STOK) Given “Buy” Rating at HC Wainwright
Defense World
Read Stoke Therapeutics (NASDAQ:STOK) Given “Buy” Rating at HC Wainwright at Defense World.
4 days ago
Stoke Therapeutics (NASDAQ:STOK) Trading Down 6.4%
MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Shares Down 6.4%
2 days ago
Stoke Therapeutics First Quarter 2024 Earnings: Beats Expectations
Yahoo Finance
Stoke Therapeutics ( NASDAQ:STOK ) First Quarter 2024 Results Key Financial Results Net loss: US$26.4m (loss widened by...
6 days ago
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Business Wire
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by...
1 month ago
Research Analysts Issue Forecasts for Stoke Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:STOK)
Defense World
Read Research Analysts Issue Forecasts for Stoke Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:STOK) at Defense World.
3 days ago
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance
Stoke Therapeutics (STOK) delivered earnings and revenue surprises of 5% and 26.61%, respectively, for the quarter ended March 2024.
1 week ago